NCT05963386
Clinical Evaluation of 177Lu-DOTA-EB-FAPI in Patients with Various Solid Tumors treatment 2 completed NCT03690869
REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma treatment 1 / 2 terminated NCT02164097
ODSH + ICE Chemotherapy in Pediatric Solid Tumors treatment 1 terminated NCT04238819
A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma treatment 1 / 2 active_not_recruiting NCT06375564
Clinical Evaluation of 177Lu-AB-3PRGD2 in Various Solid Tumors With Integrin αvβ3 Positive Expression treatment 1 recruiting NCT06577987
Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies No drug interventions treatment 1 recruiting NCT01558453
Oxaliplatin for Children With Solid Tumors treatment 2 unknown_status NCT05468359
Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients treatment 1 / 2 recruiting NCT03443622
Phase I Study of SC-43 Oral Solution in Subjects With Refractory Solid Tumors No drug interventions treatment 1 withdrawn NCT00110357
Study of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid Tumors diagnostic 1 completed NCT04718675
A Study of KB-0742 in Participants with Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC) No drug interventions treatment 1 / 2 recruiting NCT03739827
Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors No drug interventions Not Available Not Available recruiting NCT06006273
A Phase Ib Trial of Eribulin in Combination with Irinotecan and Temozolamide in Children with Relapsed or Refractory Solid Tumors treatment 1 / 2 recruiting NCT03052205
A Study of Intratumoral IMO-2125 in Patients With Refractory Solid Tumors treatment 1 completed NCT00923728
A Phase I Trial of AVN944, an IMPDH Inhibitor, in Adults With Advanced Stage Solid Tumors No drug interventions treatment Not Available withdrawn NCT00759928
PK Trial of Sorafenib & Erlotinib in Patients With Refractory Solid Tumors treatment 1 completed NCT03247309
TCR-engineered T Cells in Solid Tumors (ACTengine IMA201-101) No drug interventions treatment 1 completed NCT05811975
KSX01-TCRT Injection Project in Solid Tumors No drug interventions treatment 0 recruiting NCT04869475
Arsenic Trioxide in Refractory Solid Tumors With Rescuable p53 Mutation treatment 2 unknown_status NCT03810742
Nanoliposomal Irinotecan (Nal-IRI, ONIVYDE®) in Combination With TAS-102 (LONSURF®) in Refractory Solid Tumors treatment 1 completed NCT02450149
Single-arm Study to Evaluate the Safety and Efficacy of Sorafenib, in Subjects With BRAF Mutation Refractory Solid Tumors treatment Not Available completed NCT06150365
Single Arm Clinical Study on the Safety and Efficacy of Personalized KSX01-TCRT in Patients With Advanced Solid Tumors No drug interventions treatment 0 recruiting NCT01525394
A Double-Blind Study in Healthy Volunteers to Assess the Effect of E7080 on the QTc Interval basic_science 1 completed NCT00598091
A Phase I/Expansion Study of Dasatinib treatment 1 terminated NCT02691780
Study to Evaluate the Safety and Efficacy of Sorafenib, in Subject With Refractory Solid Tumors treatment Not Available withdrawn NCT01247168
An Open-Label, Dose-Escalation Study of AZD2461 No drug interventions treatment 1 completed NCT06030869
MyCustom:Prospective Master Protocol Trial on Precision Medicine Treatment for Refractory Solid Tumors No drug interventions Not Available Not Available recruiting NCT00394446
Phase 1, Multiple Dose Study of MPC-6827 in Subjects With Refractory Solid Tumors treatment 1 completed NCT02688881
Study to Evaluate the Safety and Efficacy of Sirolimus, in Subject With Refractory Solid Tumors treatment 4 completed NCT02450123
Single-arm Study to Evaluate the Safety and Efficacy of Sunitinib, in Subjects With RET Fusion Positive or FGFR2 Amplification, Refractory Solid Tumors treatment Not Available completed NCT02596503
A Study of Eribulin in Combination With Oral Irinotecan for Adolescent and Young Adult Patients With Relapsed or Refractory Solid Tumors treatment 1 completed NCT00665990
Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia treatment 1 completed NCT05539833
KSH01-TCRT Solid Tumors No drug interventions treatment 0 recruiting NCT02691793
Study to Evaluate the Safety and Efficacy of Sunitinib, in Subject With Refractory Solid Tumors treatment 4 completed NCT02450136
Single-arm Study to Evaluate the Safety and Efficacy of Pazopanib, in Subjects With FGFR2 Amplification, FGFR2 Mutation Refractory Solid Tumors treatment Not Available completed NCT02482441
A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10 treatment 1 completed NCT00664586
A Phase 1 Continuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid Tumors treatment 1 terminated NCT05150457
Safety and Preliminary Efficacy of BNA035 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT02512926
Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children treatment 1 completed NCT03096340
Safety and Pharmacokinetic Study of IT-141 in Monotherapy in Patients With Advanced Cancer No drug interventions treatment 1 terminated NCT02691767
Study to Evaluate the Safety and Efficacy of Pazopanib, in Subject With Refractory Solid Tumors treatment Not Available completed NCT02383368
A Dose Escalation and Expansion Study of ASP4132 to Subjects With Advanced Refractory Tumors and Lymphoma No drug interventions treatment 1 completed NCT00914914
Safety Study of a Cell Penetrating Peptide (p28) to Treat Solid Tumors That Resist Standard Methods of Treatment No drug interventions treatment 1 completed NCT00404508
A Phase II Study of Epigenetic Therapy to Overcome Chemotherapy Resistance in Refractory Solid Tumors treatment 2 completed